1. Home
  2. OABI vs NREF Comparison

OABI vs NREF Comparison

Compare OABI & NREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OABI
  • NREF
  • Stock Information
  • Founded
  • OABI 2012
  • NREF 2019
  • Country
  • OABI United States
  • NREF United States
  • Employees
  • OABI N/A
  • NREF N/A
  • Industry
  • OABI Biotechnology: Pharmaceutical Preparations
  • NREF Real Estate Investment Trusts
  • Sector
  • OABI Health Care
  • NREF Real Estate
  • Exchange
  • OABI Nasdaq
  • NREF Nasdaq
  • Market Cap
  • OABI 236.1M
  • NREF 244.3M
  • IPO Year
  • OABI N/A
  • NREF 2020
  • Fundamental
  • Price
  • OABI $1.94
  • NREF $13.94
  • Analyst Decision
  • OABI Strong Buy
  • NREF Hold
  • Analyst Count
  • OABI 3
  • NREF 3
  • Target Price
  • OABI $7.00
  • NREF $14.50
  • AVG Volume (30 Days)
  • OABI 643.9K
  • NREF 58.2K
  • Earning Date
  • OABI 08-06-2025
  • NREF 07-31-2025
  • Dividend Yield
  • OABI N/A
  • NREF 14.35%
  • EPS Growth
  • OABI N/A
  • NREF N/A
  • EPS
  • OABI N/A
  • NREF 2.59
  • Revenue
  • OABI $26,744,000.00
  • NREF $110,996,000.00
  • Revenue This Year
  • OABI N/A
  • NREF $25.18
  • Revenue Next Year
  • OABI $45.02
  • NREF $3.65
  • P/E Ratio
  • OABI N/A
  • NREF $5.39
  • Revenue Growth
  • OABI 27.07
  • NREF 370.78
  • 52 Week Low
  • OABI $1.22
  • NREF $12.14
  • 52 Week High
  • OABI $4.96
  • NREF $18.09
  • Technical
  • Relative Strength Index (RSI)
  • OABI 57.48
  • NREF 52.28
  • Support Level
  • OABI $1.93
  • NREF $13.72
  • Resistance Level
  • OABI $2.11
  • NREF $14.15
  • Average True Range (ATR)
  • OABI 0.14
  • NREF 0.28
  • MACD
  • OABI -0.00
  • NREF 0.07
  • Stochastic Oscillator
  • OABI 47.24
  • NREF 87.89

About OABI OmniAb Inc.

OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.

About NREF NexPoint Real Estate Finance Inc.

NexPoint Real Estate Finance Inc is a real estate investment trust. The company provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.

Share on Social Networks: